AI assistant
SYNECTICS PLC — Director's Dealing 2020
Jul 28, 2020
7942_dirs_2020-07-28_aae1d7b9-8ee7-4fa6-a7d8-6ee8f533cc7c.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
RNS Number : 2232U
Synectics PLC
28 July 2020
| ## 28 July 2020 |
Synectics plc
Director's Dealing
Synectics plc (AIM: SNX), a leader in the design, integration and support of advanced security and surveillance systems, has been notified that on 27 July 2020, David Bedford, Finance Director of the Company, purchased 5,000 ordinary shares of 20 pence each in the Company ("Ordinary Shares"), at 124.985 pence per share.
Following the purchase, Mr Bedford has a notifiable beneficial interest in 5,000 Ordinary Shares, representing 0.03 per cent. of the Company's issued share capital.
-ends-
About Synectics plc
Synectics (AIM: SNX) is a leader in the design, integration and support of advanced security and surveillance systems that enable clients around the world to protect their people, communities, and assets.
Founded over 30 years ago, Synectics has deep industry experience across gaming, energy, urban transport, public space and critical infrastructure projects. The group's expert engineering teams work in partnership with customers to create integrated product and technology platforms, proven in the most complex and demanding operating environments.
Find out more at www.synecticsplc.com.
For further information, please contact:
| Synectics plc | Tel: +44 (0) 114 280 2828 |
| Paul Webb, Chief Executive David Bedford, Finance Director |
|
| email: [email protected] | www.synecticsplc.com |
| Shore Capital | Tel: +44 (0) 20 7408 4050 |
| Tom Griffiths / Henry Willcocks | |
| Media enquiries: Intelligent Conversation |
Tel: +44 (0) 161 694 3979 |
| Claire Evans Email: [email protected] |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHEAXXXADSEEFA